Drugs : Actualité Drugs en direct - P1 | Bourse Reflex
Accueil > Tags > Drugs

  • Toutes les actualités en rapport avec « Drugs »

02/05 07:30 Drugs - ORAL PRESENTATION OF THERANEXUS AT THE 9TH EUROPEAN CONGRESS ON NARCOLEPSY 5 AND 6 MAY IN MONTPELLIER

26/04 18:00 Drugs - THERANEXUS ANNOUNCES ITS 2017 ANNUAL RESULTS AND PRESENTS AN UPDATE ON THE PROGRESS OF ITS CLINICAL TRIALS

23/04 07:30 Drugs - THN102 OBTAINS INVESTIGATIONAL NEW DRUG STATUS FROM THE FOOD AND DRUG ADMINISTRATION (FDA)

19/04 18:00 Drugs - THERANEXUS ANNOUNCES THE FIRST EUROPEAN APPROVAL FOR ITS PHASE 2 CLINICAL TRIAL WITH THN 102 IN PARKINSON'S DISEASE PATIENTS

19/04 17:45 Drugs - Quantum Genomics enters a new phase of maturity with its BAPAIs Fast Growth strategic plan

09/04 18:00 Drugs - Quantum Genomics strengthens its governance

29/03 18:00 Drugs - Quantum Genomics publishes its financial results for the year 2017

21/03 07:30 Drugs - THERANEXUS ANNOUNCES A SUCCESSFUL CLINICAL PHARMACOKINETIC STUDY AS PART OF THE DEVELOPMENT OF ITS DRUG CANDIDATES THN201 AND THN101

15/03 07:30 Drugs - THERANEXUS AND THE COLLEGE DE FRANCE SIGN A RESEARCH AGREEMENT ON ASTROCYTE-NEURON INTERACTIONS

05/03 18:30 Drugs - Quantum Genomics Secures Operational Flexibility and Growth Capital through Equity Line Financing with Kepler Cheuvreux

29/12 14:30 Drugs - Quantum Genomics to Present at Biotech Showcase 2018

15/11 07:30 Drugs - Quantum Genomics announces recruitment of first patients in the NEW-HOPE arterial hypertension study in the United States

27/10 07:30 Drugs - Quantum Genomics receives the Galien MedStartUp award for the innovative design of its NEW-HOPE study

16/10 18:00 Drugs - Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial

03/10 18:15 Drugs - Quantum Genomics Releases 2017 First-Half Financial Results and First Nine Months Business Update

28/09 07:30 Drugs - Theranexus files its registration document as part of its planned Initial Public Offering (IPO) on the Euronext Growth market in Paris

19/06 07:30 Drugs - Quantum Genomics details positive results from its Phase IIa trial of QGC001 for the treatment of arterial hypertension

30/03 18:00 Drugs - 2016 annual financial results and next development steps in 2017

28/02 17:45 Drugs - Genticel becomes Genkyotex: Genticel's General Meeting approves the strategic combination with GenKyoTex SA

29/11 18:15 Drugs - Initiation of coverage by Edison Investment Research